Navina and Nabla Partner to Revolutionize Clinical Workflows with AI Integration

NoahAI News ·
Navina and Nabla Partner to Revolutionize Clinical Workflows with AI Integration

In a groundbreaking move set to transform clinical workflows, AI medical scribe company Nabla has announced a strategic partnership with Navina, integrating their technologies to create a comprehensive AI-powered solution for healthcare providers. This collaboration aims to streamline clinical encounters, improve patient outcomes, and enhance financial performance for healthcare organizations.

AI-Enabled Clinical Copilot Meets Ambient Documentation

The integration combines Navina's AI-enabled clinician copilot with Nabla's in-visit ambient documentation technology. This powerful combination reconciles historical patient records with live patient dialogue, providing real-time support throughout the entire clinical encounter.

Navina's proprietary AI engine ingests Nabla's ambient conversation data and aligns it with historical records from multiple sources, including labs, imaging, unstructured notes, and audio. The result is a seamless AI layer that works alongside clinicians, ensuring appropriate care delivery, accurate code capture, and comprehensive clinical documentation.

Alex Lebrun, co-founder and CEO of Nabla, emphasized the partnership's significance: "Our collaboration with Navina reinforces our commitment to embedding deeper and broader AI capabilities across clinical workflows. We're excited about the potential this unlocks for clinicians, equipping them with timely insights to elevate patient care while maximizing documentation accuracy and reimbursement."

Addressing Healthcare Challenges and Value-Based Care Demands

The partnership comes at a crucial time for the healthcare industry, as physicians face increasing administrative burdens, tighter compliance requirements, and a shift towards value-based care models. The Centers for Medicare and Medicaid Services (CMS) and the Center for Medicare and Medicaid Innovation (CMMI) are placing greater emphasis on downside risk arrangements, making accurate and clinically grounded documentation critically important.

Navina and Nabla's joint solution aims to address these challenges by:

  1. Closing care gaps and improving audit-ready documentation
  2. Enhancing reimbursement accuracy
  3. Reducing clinician burnout
  4. Driving measurable improvements in quality metrics and risk adjustment

The integrated technology is designed to benefit various healthcare organizations, including health systems, ACOs, MSOs, and medical groups, by providing a comprehensive AI layer that supports clinical decision-making and streamlines administrative tasks.

Recent Funding Rounds Fuel Innovation

Both Navina and Nabla have recently secured significant funding to drive their technological advancements. In March, Navina raised $55 million in a Series C round backed by Growth Equity at Goldman Sachs Alternatives, along with investors Vertex Ventures Israel, Grove Ventures, and ALIVE. Last month, Nabla closed a $70 million funding round led by HV Capital.

These investments underscore the growing interest in AI-powered healthcare solutions and position both companies to continue innovating in the rapidly evolving healthcare technology landscape.

References